Neuro-oncology: Late neurocognitive decline after radiotherapy for low-grade glioma

Nature Reviews Neurology

Volumn 5, Issue 12, 2009, Pages 646-647

  Khasraw, Mustafa ^a   Lassman, Andrew B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ATTENTION DISTURBANCE; BRAIN METASTASIS; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; COGNITION; COGNITIVE DEFECT; DEMENTIA; DISEASE COURSE; DISEASE SEVERITY; GLIOMA; HUMAN; LEUKOENCEPHALOPATHY; LONG TERM CARE; MENTAL DETERIORATION; NEUROPSYCHOLOGICAL TEST; OLIGODENDROGLIOMA; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SHORT SURVEY; WHITE MATTER;

BRAIN NEOPLASMS; COGNITION DISORDERS; GLIOMA; HUMANS; RADIOTHERAPY; TIME;

EID: 74949101949     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2009.194     Document Type: Short Survey

References (11)

1. Louis, D. N. et al. WHO Classification of Tumors of the Central Nervous System, 4th edn (international Agency for Research on Cancer, Lyon, 2007).
2. Douw, L. et al. Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol. 8, 810-818 (2009).
3. Klein, M. et al. effect of radiotherapy and other treatment-related factors on mid-term to longterm cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360, 1361-1368 (2002).
4. van den Bent, M. J. et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the eORTC 22845 randomised trial. Lancet 366, 985-990 (2005).
5. Pignatti, F. et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J. Clin. Oncol. 20, 2076-2084 (2002).
6. Olson, J. D., Riedel, E. & DeAngelis, L. M. Longterm outcome of low-grade oligodendroglioma and mixed glioma. Neurology 54, 1442-1448 (2000).
7. Mariani, L. et al. Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse wHO grade 2 gliomas treated without chemotherapy. J. Clin. Oncol. 24, 4758-4763 (2006).
8. Smith, J. S. et al. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J. Clin. Oncol. 26, 1338-1345 (2008).
9. DeAngelis, L. M., Delattre, J. Y. & Posner, J. B. Radiation-induced dementia in patients cured of brain metastases. Neurology 39, 789-796 (1989).
10. Patchell, R. A. et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280, 1485-1489 (1998).
11. Lassman, A. B. et al. international retrospective study of 1,000+ adults with anaplastic oligodendroglial tumors [Abstract 283]. Neuro. Oncol. 11, 629 (2009).